IPO Boutique

Cue Biopharma, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Cue Biopharma, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Cue Biopharma, Inc.CUE -
NASDAQ
$7.50-$7.50 $7.50 $11.998.8 million1/2/2018
MDB Capital, Feltl and Company
Co-Manager(s):
Health Care
Filing(s):

Filed 2017-09-21
Terms Added 2017-11-02
Updated Prospectus 2017-11-17



Cue Biopharma, Inc. Quote & Chart - Click for current quote - CUE

About Cue Biopharma, Inc. (adapted from Cue Biopharma, Inc. prospectus):
They are an innovative biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "CUE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved